Furthermore, the expression level of Bax was significantly increased and the Bcl-2 level was decreased in 231/PTX cells treated with PTX plus UA compared with the levels in cells treated with PTX only (Figure 1G).These results suggest that UA could reverse PTX resistance in breast cancer cells. The gene discussed is BCL2; the disease is breast carcinoma.